Macrophage-Directed Cancer Immunotherapy
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Cancer Immunology and Immunotherapy".
Deadline for manuscript submissions: 31 December 2024 | Viewed by 2015
Special Issue Editor
Special Issue Information
Dear Colleagues,
Welcome to our highly acclaimed Special Issue entitled "Macrophage-Directed Cancer Immunotherapy", which explores the dynamic landscape of using macrophages in innovative cancer treatments. The objective of this Special Issue is to consolidate the latest research focusing on the central role of macrophages in the formation of tumor immunity and their potential as therapeutic targets. We welcome contributions that clarify the modulation, polarization, and interactions within the tumor microenvironment and their manipulation for effective immunotherapy. The scope of this Special Issue includes research on novel strategies, preclinical and clinical advances, biomarkers, and the evolving landscape of macrophage-based interventions in cancer. Join us in deciphering the complexity and promises of macrophage-centered immunotherapy to restructure the cancer treatment landscape. We invite you to submit your research papers, reviews, editorials, and communications to this Special Issue to advance the boundaries of cancer immunotherapy.
Dr. Zahra Payandeh
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- macrophage
- cancer
- immunotherapy